117 related articles for article (PubMed ID: 7012606)
1. Enhancement of hepatic microsome-mediated bacterial mutagenesis by the rat liver soluble protein fraction.
Saccone GT; Pariza MW
Mutat Res; 1981 Feb; 88(2):135-45. PubMed ID: 7012606
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of N-hydroxy-2-aminofluorene bacterial mutagenicity by the soluble protein fraction from rat liver and partial purification of the enhancement activity.
Saccone GT; DasGupta BR; Pariza MW
Cancer Res; 1981 Nov; 41(11 Pt 1):4600-5. PubMed ID: 7030478
[TBL] [Abstract][Full Text] [Related]
3. The mutagenicity of aflatoxin Q1 to Salmonella typhimurium TA 100 with or without rat or human liver microsomal preparations.
Yourtee DM; Kirk-Yourtee CL
Res Commun Chem Pathol Pharmacol; 1986 Oct; 54(1):101-13. PubMed ID: 3099349
[TBL] [Abstract][Full Text] [Related]
4. Genetic expression of aflatoxin metabolism. Effects of 3-methylcholanthrene and beta-naphthoflavone on hepatic microsomal metabolism and mutagenic activation of aflatoxins.
Raina V; Williams CJ; Gurtoo HL
Biochem Pharmacol; 1983 Dec; 32(24):3755-63. PubMed ID: 6318770
[TBL] [Abstract][Full Text] [Related]
5. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
6. Mutagenic activity of biliary metabolites of 6-hydroxymethylbenzo[a]pyrene.
Hughes MF; Kadry AR; Gairola CG; Flesher JW
Mutat Res; 1986 Apr; 173(4):251-6. PubMed ID: 3513004
[TBL] [Abstract][Full Text] [Related]
7. Specificity of rat liver cytochrome P-450 isozymes in the mutagenic activation of benzo[a]pyrene, aromatic amines and aflatoxin B1.
Robertson IG; Zeiger E; Goldstein JA
Carcinogenesis; 1983; 4(1):93-6. PubMed ID: 6295661
[TBL] [Abstract][Full Text] [Related]
8. The reduced mutagenicity of aflatoxin B1 due to hydroxylation: observations on five Salmonella typhimurium tester strains.
Uwaifo AO; Bababunmi EA
Cancer Lett; 1979 Aug; 7(4):221-5. PubMed ID: 389414
[TBL] [Abstract][Full Text] [Related]
9. Effect of glutathione and uridine 5'-diphosphoglucuronic acid on benzo(a)pyrene mutagenesis in the Salmonella/microsome assay.
Malaveille C; Brun G; Hautefeuille A; Bartsch H
Dev Toxicol Environ Sci; 1980; 8():175-80. PubMed ID: 6273102
[No Abstract] [Full Text] [Related]
10. Test-condition-dependent influence of harman and nonharman on benzo[a]pyrene mutagenesis in Salmonella.
Riebe M; Westphal K; Keller H
Mutat Res; 1982 Apr; 104(1-3):9-15. PubMed ID: 7043258
[TBL] [Abstract][Full Text] [Related]
11. The metabolic activation of benzo(a)pyrene and 9-hydroxybenzo(a)pyrene by liver microsomal fractions.
Lubet RA; Capdevila J; Prough RA
Int J Cancer; 1979 Mar; 23(3):353-7. PubMed ID: 374283
[TBL] [Abstract][Full Text] [Related]
12. Effects of vitamins A, C, and E on aflatoxin B1-induced mutagenesis in Salmonella typhimurium TA-98 and TA-100.
Raina V; Gurtoo HL
Teratog Carcinog Mutagen; 1985; 5(1):29-40. PubMed ID: 2859659
[TBL] [Abstract][Full Text] [Related]
13. Kinetics of benzo[a]pyrene induced mutagenesis in a highly sensitive salmonella/microsome assay.
Unger J; Guttenplan JB
Mutat Res; 1980 Mar; 77(3):221-8. PubMed ID: 6991920
[TBL] [Abstract][Full Text] [Related]
14. Apparent activation of 2-acetylaminofluorene and some aromatic amines by cytosolic preparations.
Forster R; Green MH; Priestley A; Gorrod JW
Mutat Res; 1981 Aug; 85(4):187-94. PubMed ID: 7022188
[TBL] [Abstract][Full Text] [Related]
15. Presentation of benzo(a)pyrene to microsomal enzymes by asbestos fibers in the Salmonella/mammalian microsome mutagenicity test.
Szyba K; Lange A
Environ Health Perspect; 1983 Sep; 51():337-41. PubMed ID: 6315376
[TBL] [Abstract][Full Text] [Related]
16. Comparison of rat and guinea pig as sources of the S9 fraction in the Salmonella/mammalian microsome mutagenicity test.
Baker RS; Bonin AM; Stupans I; Holder GM
Mutat Res; 1980 Jun; 71(1):43-52. PubMed ID: 6993931
[TBL] [Abstract][Full Text] [Related]
17. Promutagen activation in partially hepatectomized mice.
Vandewaa EA; Barney CC; Gentile JM
Toxicol Lett; 1982 Dec; 14(3-4):253-60. PubMed ID: 6820200
[TBL] [Abstract][Full Text] [Related]
18. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
19. Multiple metabolic pathways for the mutagenic activation of 3-nitrobenzo[a]pyrene.
Chou MW; Heflich RH; Fu PP
Carcinogenesis; 1985 Aug; 6(8):1235-8. PubMed ID: 3893788
[TBL] [Abstract][Full Text] [Related]
20. The Salmonella/mammalian microsome mutagenicity test: comparison of human and rat livers as activating systems.
Beaune P; Lemestré-Cornet R; Kremers P; Albert A; Gielen J
Mutat Res; 1985 Jun; 156(3):139-46. PubMed ID: 3889631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
